California Judge Upholds Morrison & Foerster’s Role in High-Stakes Biometric Patent Case

A California federal judge recently denied a motion by FaceTec, a biometric security company, to disqualify Morrison & Foerster LLP from representing a competitor in a patent infringement lawsuit. This decision follows the ouster of Perkins Coie, which initially faced a similar disqualification attempt. This ruling underscores the complex dynamics of legal representation in high-stakes…

Read More

Legal Precedent Set as Judge Disqualifies Verizon’s Attorneys Amidst Patent Litigation Conflict

In a recent decision affecting a high-stakes patent litigation, a federal judge in Texas affirmed a magistrate judge’s ruling to disqualify WilmerHale attorneys from representing Verizon in its ongoing legal battle with Headwater Research LLC. The disqualification is rooted in a conflict of interest, as WilmerHale previously represented the owner of the patents under dispute….

Read More

Startup Advocates Push Federal Circuit to Uphold USPTO’s Discretionary Denials Policy Amid SAP Challenge

In a recent legal development, organizations representing startups and intellectual property owners have urged the Federal Circuit to dismiss SAP America Inc.’s petition for mandamus. This petition challenges the discretionary denials policy managed by the U.S. Patent and Trademark Office (USPTO). The concerned parties argue that the USPTO’s decision-making fell within the scope of its…

Read More

Calls for Federal Intervention Grow as Xtandi Drug Pricing Sparks National Debate

The ongoing debate over the pricing of Xtandi, a prostate cancer medication developed at the University of California, Los Angeles (UCLA) and marketed by Pfizer, has intensified with renewed calls for the federal government to intervene by permitting generic competition. This development coincides with Health and Human Services Secretary Robert F. Kennedy Jr.’s recent confirmation,…

Read More

Federal Judge Halts Generic Production in Selenium Injection Patent Dispute

A New Jersey federal judge has enacted a temporary injunction against several generic-drug manufacturers, preventing them from distributing their versions of a selenium injection treatment. This legal action arises amidst claims of patent infringement from American Regent Inc., the patent holder of the injectable selenium product. According to a recent report, the company’s legal team…

Read More

Key Developments in U.S. Intellectual Property Law: USPTO and Copyright Office Adapt to AI and Innovation in 2025

In the first half of 2025, the U.S. Patent and Trademark Office (USPTO) and the U.S. Copyright Office have introduced several initiatives and policy changes that significantly impact intellectual property (IP) law and practice. In January, the USPTO unveiled its Artificial Intelligence (AI) Strategy, aiming to integrate AI technologies into patent and trademark examination processes….

Read More

U.S. Intellectual Property Agencies Navigate Leadership Changes and Policy Reforms in 2025

The first half of 2025 has been marked by significant developments within the United States’ intellectual property agencies, notably the U.S. Patent and Trademark Office (USPTO) and the U.S. Copyright Office. These changes encompass leadership transitions, policy revisions, and procedural updates, reflecting the evolving landscape of intellectual property law. Leadership Changes at the USPTO In…

Read More

Federal Circuit Temporarily Blocks Generic Entresto Amid Novartis Appeal

The U.S. Court of Appeals for the Federal Circuit has temporarily halted MSN Pharmaceuticals from launching a generic version of Novartis’ heart-failure medication, Entresto. This decision provides Novartis with a brief respite following a recent unfavorable ruling in a Delaware district court. On July 11, 2025, U.S. District Judge Richard Andrews in Delaware denied Novartis’…

Read More

PTAB Invalidates Aerin Medical’s Nasal Treatment Patents, Bolstering Neurent Medical’s Competitive Position

The Patent Trial and Appeal Board (PTAB) recently invalidated several claims within three nasal airway treatment patents held by Aerin Medical. This decision aligns with Neurent Medical’s challenge that the claims lacked novelty and were obvious. The contested patents were scrutinized under the agency’s procedure that allows third parties to challenge patent validity on grounds…

Read More

TikTok Faces Intellectual Property Challenge in Chinese Video-Editing Technology Dispute

In a legal battle that underscores the complexities of intellectual property rights in the tech industry, TikTok and a Chinese company are embroiled in a dispute over ownership and use of video-editing technology. The conflict has surfaced through motions for summary judgment filed by both parties, each claiming stakes over the technology’s inception and use….

Read More

Verizon Faces Legal Setback as WilmerHale Disqualified in High-Stakes Patent Case

In a significant development in the ongoing litigation between Verizon and Headwater Research, a federal magistrate judge in Texas has disqualified the law firm WilmerHale from representing the telecommunications giant. This decision was made just before what promised to be a contentious trial over allegations that Verizon had infringed on patents related to wireless communications…

Read More

Federal Judge Disqualifies WilmerHale from Verizon Patent Case in Texas Over Conflict of Interest

A recent decision by a federal magistrate judge in Texas has led to the disqualification of the law firm WilmerHale from representing telecommunications giant Verizon in an upcoming trial. The case centers on allegations that Verizon infringed on patents related to wireless communications owned by Headwater Research. This ruling came just as the trial was…

Read More

USPTO Director Criticizes Proposed Treaty on Indigenous Knowledge Disclosure in Patent Applications

On July 14, 2025, the acting director of the U.S. Patent and Trademark Office (USPTO) expressed concerns about an emerging international treaty focused on the protection of indigenous knowledge in patent applications. This stance challenges a proposal that seeks to mandate patent applicants to disclose whether their inventions incorporate traditional knowledge from indigenous communities. The…

Read More

Federal Circuit Upholds PTAB’s Invalidation of Johnson & Johnson’s Catheter Patent Amid Abbott Challenge

The Federal Circuit has reaffirmed the Patent Trial and Appeal Board’s (PTAB) decision to invalidate a Johnson & Johnson subsidiary’s patent pertaining to a catheter device used for clearing clogged arteries. Abbott Laboratories had contested the patent, arguing that the stated invention was already recognized as an earlier creation within the patent itself. This ruling…

Read More

Johnson & Johnson’s Legal Battle with Sun Pharma Intensifies Over Invega Sustenna Patents

Following a favorable ruling from the Federal Circuit, Johnson & Johnson’s Janssen subsidiaries have initiated lawsuits against Sun Pharma in federal courts in New Jersey and Delaware. These legal actions were prompted by Sun Pharma’s intent to market generic versions of Janssen’s schizophrenia medication, Invega Sustenna. Janssen’s recent victory at the Federal Circuit reinforced its…

Read More

Federal Judge Dismisses WinView’s Patent Infringement Claims Against DraftKings

In a noteworthy legal development, a federal judge in New Jersey has dismissed allegations against DraftKings Inc., concerning the unauthorized use of patented features in its mobile sports betting and fantasy game application. The ruling came after WinView Inc. accused DraftKings of infringing on its patents, claiming that key elements of their application had been…

Read More

IonQ Strengthens Legal Expertise with Tom Jones as New Chief Legal Officer Amid Quantum Computing Growth

IonQ, a significant player in the quantum computing industry, has announced the appointment of Tom Jones, a seasoned technology legal expert, as their new Chief Legal Officer (CLO). This move comes as IonQ continues to bolster its executive team amidst growing interest and investment in quantum technologies. Tom Jones brings with him extensive experience from…

Read More

Trademark Tensions: AI Branding Disputes Highlight Need for Strategic Protection

The rapid expansion of artificial intelligence into hardware has intensified focus on branding and intellectual property. Recent legal disputes involving OpenAI underscore the critical importance of robust brand protection strategies. In June 2025, AI hardware startup iyO Inc. filed a trademark infringement lawsuit against OpenAI and designer Jony Ive. The contention arose after OpenAI announced…

Read More

AI Investment Surge Reshapes Intellectual Property Landscape, WIPO Reports

Artificial intelligence continues to reshape the landscape of intellectual property and intangible assets, driving substantial growth that outpaces traditional physical asset investments. Recent findings highlight that investments in software, brands, and patents have expanded over three times faster than physical assets since 2008, according to a recent report by the World Intellectual Property Organization (WIPO)….

Read More

California Judge Sanctions Texas Attorney for Breaching Netflix’s Confidential Data Protection

A California federal judge has sanctioned Texas attorney Bill Ramey for violating a protective order by sharing Netflix Inc.’s confidential information with litigation funder AiPi LLC. However, the judge declined to hold him in contempt. Judge Jon S. Tigar of the U.S. District Court for the Northern District of California found Ramey’s justification for disclosing…

Read More

“New U.S. Patent Policies Signal Strengthened IP Protections for High-Tech Sector”

Recent developments in U.S. intellectual property (IP) policy signal a more favorable environment for patent holders in the high-tech sector. Changes within the U.S. Patent and Trademark Office (USPTO), coupled with broader regulatory initiatives, are poised to enhance protections for patent owners. The USPTO has introduced interim processes that could reduce the role of the…

Read More